SORRENTINO, RAFFAELLA
 Distribuzione geografica
Continente #
EU - Europa 6.790
AS - Asia 5.648
NA - Nord America 4.301
SA - Sud America 804
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 17.695
Nazione #
US - Stati Uniti d'America 4.105
SG - Singapore 3.204
IT - Italia 2.911
RU - Federazione Russa 2.094
CN - Cina 1.258
BR - Brasile 640
HK - Hong Kong 505
VN - Vietnam 301
DE - Germania 282
NL - Olanda 264
UA - Ucraina 258
FI - Finlandia 224
IE - Irlanda 186
GB - Regno Unito 154
FR - Francia 153
CA - Canada 111
SE - Svezia 71
IN - India 62
AR - Argentina 55
MX - Messico 52
TR - Turchia 45
KR - Corea 43
ZA - Sudafrica 43
CI - Costa d'Avorio 42
PL - Polonia 36
BD - Bangladesh 35
EC - Ecuador 35
ID - Indonesia 32
JP - Giappone 30
ES - Italia 25
AT - Austria 21
IQ - Iraq 17
PK - Pakistan 16
VE - Venezuela 16
CO - Colombia 15
LT - Lituania 15
MA - Marocco 15
PY - Paraguay 15
RS - Serbia 14
BE - Belgio 12
CH - Svizzera 12
AE - Emirati Arabi Uniti 10
PE - Perù 10
SA - Arabia Saudita 10
IR - Iran 9
CZ - Repubblica Ceca 8
KE - Kenya 8
LB - Libano 7
TN - Tunisia 7
UY - Uruguay 7
UZ - Uzbekistan 7
AL - Albania 6
CL - Cile 6
DK - Danimarca 6
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
JO - Giordania 6
TW - Taiwan 6
AM - Armenia 5
AZ - Azerbaigian 5
GR - Grecia 5
JM - Giamaica 5
MY - Malesia 5
HR - Croazia 4
LC - Santa Lucia 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
ME - Montenegro 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
AF - Afghanistan, Repubblica islamica di 2
AU - Australia 2
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
DJ - Gibuti 2
GA - Gabon 2
GF - Guiana Francese 2
GH - Ghana 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
Totale 17.670
Città #
Singapore 1.434
Hong Kong 504
Moscow 475
Beijing 388
Naples 372
Ashburn 336
Chandler 327
Hefei 232
Santa Clara 211
Millbury 193
Napoli 181
Princeton 169
Dallas 156
Jacksonville 151
Amsterdam 150
Nanjing 127
Los Angeles 123
Boston 105
San Jose 103
Ho Chi Minh City 100
Rome 98
Milan 83
Wilmington 80
Buffalo 76
Redondo Beach 73
Munich 69
São Paulo 65
Seattle 58
Woodbridge 56
Ottawa 55
Hanoi 52
The Dalles 45
Des Moines 43
Nanchang 43
New York 41
Seoul 41
Salerno 38
Caserta 36
Florence 36
Tianjin 36
Cagliari 34
Perugia 34
Houston 33
Chicago 32
Mexico City 30
Turku 30
Orem 28
Tokyo 28
Bologna 27
Shenyang 27
Catania 25
London 25
Warsaw 25
Brooklyn 24
Rio de Janeiro 23
Turin 23
Ann Arbor 22
Dong Ket 22
Hebei 22
Nuremberg 22
Chennai 21
Mugnano di Napoli 21
Helsinki 20
Frankfurt am Main 19
Denver 18
Guayaquil 18
Haiphong 18
Messina 18
Bari 17
Belo Horizonte 17
Dearborn 17
Jiaxing 17
Johannesburg 17
Montreal 17
San Francisco 17
Stockholm 17
Norwalk 16
Southwark 16
Toronto 16
Acerra 15
Changsha 15
Falkenstein 15
Palermo 15
Phoenix 15
Aversa 14
Falls Church 14
Lappeenranta 13
Poplar 13
Salt Lake City 13
Ankara 12
Avellino 12
Boardman 12
Casoria 12
Guangzhou 12
Marsala 12
Vallo della Lucania 12
Augusta 11
Lawrence 11
Manchester 11
Pescara 11
Totale 8.104
Nome #
Attività antinfiammatoria dei Glucocorticoidi: nuovi mediatori e regolazione dell'attività dei linfociti T 1.357
MECCANISMI FISIOLOGICI E FISIOPATOLOGICI RESPONSABILI DELL'EREZIONE PENIENA: RUOLODELL'UROTENSINA II 738
2007XKCCWF_002Ruolo della sfingosina-1-fosfato (S1P) nell'infiammazione delle vie respiratorie e nella iper-responsività in topi sensibilizzati con ovalbumina: studi in vitro 380
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 160
Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and Renin Angiotensin system 157
2009WE7L2E_003Ruolo della sfingosina-1-fosfato (S1P) nell'infiammazione polmonare e nel rimodellamento delle vie aeree: valutazioni molecolari e funzionali 141
Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease 136
Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio 135
Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway 133
null 132
Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat 129
Identification of a pepducin acting as S1P3 receptor antagonist 129
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors 128
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 126
SPHINGOSINE-1PHOSPHATE INDUCES ENDOTHELIAL NOS ACTIVATION THROUGH PHOSPHORYLATION IN HUMAN CORPUS CAVERNOSUM 123
Synthesis, biological activity and conformational study of 1,4-benzoxazine dderivatives as potassium channel modulators. 122
TITOLO: ANTICORPO ANTI CISTATIONINA BETA SINTASI FOSFORILATA E USO DELLO STESSO 122
Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin 118
Hydrogen sulphide enhances human platelet aggregation through phospholipase A2 activation 117
ENABLING PULMONARY DELIVERY OF SIRNA IN CYSTIC FIBROSIS LUNG INFLAMMATION THROUGH HYBRID LIPID/POLYMER NANOPARTICLES 117
Uterine dysfunction in diabetic mice: the role of hydrogen sulfide 116
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53 115
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference? 113
A new original nutraceutical formulation ameliorates the effect of Tadalafil on clinical score and cGMP accumulation 112
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia 111
Biodegradable particles for local and prolonged delivery of an oligonucleotide decoy to nuclear factor-kB in the lung 111
Synthesis by microwave irradiation of a substituted benzoxazine parallel library with preferential relaxant activity for guinea pig trachealis 109
β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide 108
Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner 108
Involvement of nitric oxide and hydrogen sulfide in glucorticoid-induced hypertension in rat 107
Involvement of proteinase activated receptor-2 in vascular response to sphingosine-1-phosphate 105
Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips 104
A new therapeutic approach to erectile dysfunction: Urotensin-II receptor high affinity agonist ligands 104
Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines 102
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. 102
Urotensin II: A Novel Target in Human Corpus Cavernosum 102
Intra-tracheal administration increases gallium availability in lung: implications for antibacterial chemotherapy 102
Improving therapy of lung inflammation by inhalable powders for prolonged release of a decoy oligonucleotide against NF-kB 100
Biphasic inflammatory response induced by intra-plantar injection of L-cysteine: Role of CBS-derived H2S and S1P/NO signaling 99
IDENTIFICATION AND PARTIAL PURIFICATION OF AN ENDOTHELIAL-DERIVED RELAXING FACTOR(S) IN SERUM OF HYPERTENSIVE PREECLAMPTIC PARTURIENTS. 99
Impaired vascular functions in balloon-injured rat carotid artery. 99
Synthesis, Biological Activity and Conformational Study of 1,4-Benzoxazine Derivatives as Potassium Channel Modulators 99
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide 99
Hydrogen sulfide compensates nitric oxide deficiency in murine corpus cavernosum 99
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 98
Hydrogen sulphide induced-dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed 98
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 98
Synthesis and vasorelaxant activity of new 1,4-benzoxazine derivatives potassium channel openers. 97
Hydrogen sulphide enhances human platelet aggregation through PLA2 activation 97
Anti-virulence therapy against Pseudomonas aeruginosa: identification of antibiofilm drugs and development of inhalable Niclosamide and Flucytosine Formulations 97
Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2 94
Endogenous urotensin II selectively modulates erectile function through eNOS 94
New mechanism for the beneficial effect of sildenafil on erectile function: H2S. 94
Searching for Novel Sources of Hydrogen Sulfide Donors: Chemical Profiling of Polycarpa aurata Extract and Evaluation of the Anti-Inflammatory Effects 93
UROTENSIN II AS A POSSIBLE SERUM MARKER OF ERECTILE DYSFUNCTION 93
An ex vivo standardized assay to measure human platelet cGMP 92
Centro Interdipartimentale di Ricerca Preclinica e Clinica di Medicina Sessuale (C.I.R.M.S.) 92
Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology. 92
The endocrine disruptor vinclozolin causes endothelial injury via eNOS/Nox4/IRE1α signaling 91
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 91
The Role of Perivascular Adipose Tissue-Derived Hydrogen Sulfide in the Control of Vascular Homeostasis 90
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF P. AERUGINOSA LUNG INFECTIONS THROUGH SUSTAINED-RELEASE DRY POWDERS FOR INHALATION 90
Gestosi ed Ossido di Azoto. 89
Novel Strategies for Tackling Inflammatory Respiratory Diseases based on the Exploitation of the Proresolving Receptor FPR2/ALX 88
Endogenous urotensin–II induced-penile erection trhough eNOS phosphorylation in human corpus cavernosum 88
Involvement of Hydrogen Sulfide (H2S) in Dexamethasone (DEX) Induced Hypertension in Rat 88
Recombinant human erythropoietin prevents lipolysaccharide-induced vascular hyporeactivity in the rat 88
EFFECT OF SPIRONOLACTONE AND ITS METABOLITES ON CONTRACTILE PROPERTY OF ISOLATED RAT AORTA RINGS 87
l-Cysteine/H2S pathway involvement in human platelet aggregation 87
PEI-Engineered Respirable Particles Delivering a Decoy Oligonucleotide to NF-kB: Inhibiting MUC2 Expression in LPS-Stimulated Airway Epithelial Cells 86
Characterization and quantification of intact glucosinolates in Catozza rapeseeds: A promising food matrix for nutraceuticals development as a source of hydrogen sulfide 85
Respirable large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB: in vitro/in vivo potential in cystic fibrosis 85
L-Cys/CSE/H2S pathway modulates mouse uterus motility and sildenafil effect 85
Defective protein persulfidation is involved in obesity associated skeletal muscle dysfunction: role of SIRT-1 84
Contribute of the L-cysteine/ H2S pathway in placenta homeostasis in hypertensive disorders 84
Invovement of beta-3-adrenergic receptor activation via Cyclic GMP-but not No-dependent mechanism in human corpus cavernosum function. 83
Is vascular reactivity improvements related to the re-endothelization in balloon-injured rat carotid artery ? 83
Involvement of L-cysteine/H2S pathway in human bladder homeostasis 83
Somministrazione polmonare di siRNA nel trattamento dell’infiammazione polmonare in fibrosi cistica: potenziale terapeutico di nanoparticelle ibride a base di lipidi e polimeri 83
Indomethacin and thromboxane A2/prostaglandin H2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats. 82
New interventional approaches on multiple inflammatory pathways involved in regeneration after trauma and aging- associated diseases 81
Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation 81
Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. 81
Hydrogen sulphide-induced mouse paw edema involves phospholipase A2 activation. 80
HYDROGEN SULPHIDE-INDUCED MOUESE PAW EDEMA INVOLVES PHOSPHOLIPASE A2 ACTIVATION 79
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs 78
β(3) adrenergic receptor activation relaxes human corpus cavernosum and penile artery through a hydrogen sulfide/cGMP-dependent mechanism 78
L-cysteine/cystathionine-β-synthase-induced relaxation in mouse aorta involves a L-serine/sphingosine-1-phosphate/NO pathway 78
Large Porous Particles contenenti ciclodestrine per il rilascio modificato di insulina ai polmoni: studi in vivo 77
Pulmonary delivery of insulin by large porous particles: in vitro/in vivo studies 77
Progetto tesi Dottorato (dott.ssa Donnarumma Erminia): Ruolo fisio-patologico della pathway L-cisteina/acido solfidriconell’apparato urogenitale umano 77
Large porous particles per il rilascio controllato al polmone di un decoy ODN contro NF-kB per il trattamento della fibrosi cistica: studi tecnologico-formulativi 77
Hydrogen Sulfide and Urogenital Tract 77
Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections 77
EDRF-INDUCED RELAXATION OF RABBIT AORTA RINGS IS IMPAIRED BY SOME PRODUCTS OF PROTEIN CATABOLISM 76
P5U and urantide modifi ed at position 7 with Tpi 76
A new approach for cystic fibrosis treatment: large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB in the lung 76
A standardized procedure for using human corpus cavernosum stripa to evaluate drug activity and the role of mediators in Erectile Dysfunctions 76
Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity 76
In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery 76
Totale 12.008
Categoria #
all - tutte 57.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 0 0 87 48 104 22 123 70
2021/20221.274 33 22 42 17 18 69 75 52 233 91 174 448
2022/20231.320 197 79 34 62 144 118 48 119 170 189 109 51
2023/20241.348 82 107 213 91 98 94 74 142 46 50 233 118
2024/20255.507 349 332 79 209 118 281 599 322 532 552 1.641 493
2025/20265.913 1.088 763 1.057 870 1.586 399 150 0 0 0 0 0
Totale 18.075